Galmed Pharmaceuticals Lt...

NASDAQ: GLMD · Real-Time Price · USD
1.43
-0.05 (-3.38%)
At close: Aug 15, 2025, 3:59 PM
1.47
3.14%
After-hours: Aug 15, 2025, 07:58 PM EDT

Galmed Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.65M 2.86M 2.02M 2.88M
Short-Term Investments
10.68M 9.78M 11.77M 31.93M
Long-Term Investments
2.12M 3.27M 1.5M n/a
Other Long-Term Assets
257K n/a n/a n/a
Receivables
209K 165K n/a 79K
Inventory
n/a n/a 114K -932K
Other Current Assets
121K 117K n/a 114K
Total Current Assets
16.12M 13.24M 14.72M 36.05M
Property-Plant & Equipment
n/a 125K 337K 551K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.38M 3.39M 1.84M 551K
Total Assets
18.5M 16.63M 16.56M 36.6M
Account Payables
1.31M 1.88M 2.56M 4.87M
Deferred Revenue
n/a n/a -171K n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
603K 571K 363K 1.01M
Total Current Liabilities
2.17M 2.75M 3.09M 5.88M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 44K 229K
Total Liabilities
2.17M 2.75M 3.14M 6.11M
Total Debt
n/a 41K 44K 229K
Common Stock
742K 209K 70K 70K
Retained Earnings
-200.47M -192.95M -186.04M -168.17M
Comprehensive Income
-416K -454K -745K -171K
Shareholders Equity
16.33M 13.88M 13.42M 30.5M
Total Investments
12.8M 13.05M 13.27M 31.93M